Latest News
Original English headlines · Newest first · U.S. Eastern Time
CSL strikes $1.6B deal with Alentis for experimental kidney, liver drugAsian Stocks to Rise as Hike Bets Ease, Oil Climbs: Markets WrapSchneider Said to Near Deal to Buy PTC for More Than $20 BillionAkzoNobel to sell unit to Nippon Paint for over $1 billion, FT reportsA bear-case scenario for the long-term, diversified stock market investor 📉The Biggest Risk Everyone Already Knows AboutUlta Beauty tops consumer discretionary gainers in Q3; MGM Resorts declines#ULTAConsumer staples sector falls 3% in Q3 as oil, inflation and tech rotation weighWall Street Strategists Steer Investors to Cross-Asset HedgesAI spending to drive another strong S&P 500 earnings season, Goldman Sachs saysCorporate America has never been this upbeat about future profitsEM Investors Shrug Off Quarter’s Pullback, Double Down on Carry TradesWall Street’s AI Party Is on Edge as Soaring Yields Raise RisksJobs Slow but Inflation Keeps Fed on AlertOctober can be a scary month for stocks. Here’s what investors need to watch this year.Can America Break China’s Grip on Rare Earths?Next →